(Q37575617)

21 August 2017

1 reference

title

How is gene-expression profiling going to challenge the future management of lung cancer? (English)

1 reference

21 August 2017

Edgardo S Santos

1

1 reference

21 August 2017

Cesar A Perez

series ordinal

2

1 reference

21 August 2017

Luis E Raez

series ordinal

3

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

5

1 reference

21 August 2017

issue

6

1 reference

21 August 2017

page(s)

827-835

1 reference

21 August 2017

cites work

Cancer statistics, 2008

1 reference

BRCA1: a novel prognostic factor in resected non-small-cell lung cancer

21 January 2018

1 reference

An overview of lung cancer genomics and proteomics

21 January 2018

1 reference

From cancer genomics to thoracic oncology: discovery of new biomarkers and therapeutic targets for lung and esophageal carcinoma

21 January 2018

1 reference

Complex networks orchestrate epithelial-mesenchymal transitions

21 January 2018

1 reference

Differential expression and distribution of epithelial adhesion molecules in non-small cell lung cancer and normal bronchus.

21 January 2018

1 reference

Chromosomal aberrations and gene expression profiles in non-small cell lung cancer

21 January 2018

1 reference

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

21 January 2018

1 reference

Diversity of gene expression in adenocarcinoma of the lung

21 January 2018

1 reference

Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts

21 January 2018

1 reference

A gene expression signature predicts survival of patients with stage I non-small cell lung cancer

21 January 2018

1 reference

A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.

21 January 2018

1 reference

A five-gene signature and clinical outcome in non-small-cell lung cancer

21 January 2018

1 reference

Predicting survival within the lung cancer histopathological hierarchy using a multi-scale genomic model of development

21 January 2018

1 reference

Genomic signatures to guide the use of chemotherapeutics.

21 January 2018

1 reference

Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles

21 January 2018

1 reference

Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung

21 January 2018

1 reference

Accurate molecular classification of human cancers based on gene expression using a simple classifier with a pathological tree-based framework.

21 January 2018

1 reference

Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung

21 January 2018

1 reference

Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.

21 January 2018

1 reference

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer

21 January 2018

1 reference

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial

21 January 2018

1 reference

Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group

21 January 2018

1 reference

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles.

21 January 2018

1 reference

Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients

21 January 2018

1 reference

Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma

21 January 2018

1 reference

Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection

21 January 2018

1 reference

Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

21 January 2018

1 reference

Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?

21 January 2018

1 reference

Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy

21 January 2018

1 reference

Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs

21 January 2018

1 reference

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

21 January 2018

1 reference

Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer

21 January 2018

1 reference

RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer.

21 January 2018

1 reference

Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study

21 January 2018

1 reference

Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FON.09.60

1 reference

21 August 2017

1 reference